Drug intelligence / Profile preview

NT-GA

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

NT-GA is a combination dietary herbal supplement composed of rhubarb, ginger, astragulus, red sage, and turmeric (NT), combined with gallic acid (GA). It was investigated for its potential to reduce food intake and induce weight loss. Clinical trials showed that while the combination was well tolerated, it was ineffective in causing weight loss or suppressing food intake. Pharmacokinetic studies suggested that the lack of efficacy might be due to limited oral absorption of gallic acid, as its plasma levels did not increase significantly and were not dose-related.

Beyond the preview

Go deeper on NT-GA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NT-GA.

Explore the full profile